✦ LIBER ✦

Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil

✍ Scribed by Mariantonietta Colozza; Maurizio Tonato; Fausto Grignani; Stephen Davis

Publisher: John Wiley and Sons
Year: 1988
Tongue: English
Weight: 345 KB
Volume: 62
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19880715)62:2<262::aid-cncr2820620206>3.0.co;2-c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adriamycin, dibromodulcitol, and mitomyc

Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone

✍ Kavitha Pinnamaneni; Hwee-Yong Yap; Aman U. Buzdar; Alfred Distefano; George R. 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 351 KB 👁 2 views

Results and long term follow-up for 1581

Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy : A reference

✍ Zia U. Rahman; Debbie K. Frye; Terry L. Smith; Lina Asmar; Richard L. Theriault; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 2 views

The authors report results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with doxorubicin-containing combination chemotherapy at a single institution; this report is meant to serve as a reliable reference for single-arm studies of newer therapies in this patient

Mitoxantrone, 5-fluorouracil, and high d

Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma : A randomized Phase II trial

✍ John D. Hainsworth; Jacques Jolivet; Robert Birch; Lisa G. Hopkins; F. Anthony G 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 1 views

Tenfour patients were treated with NFL: mitoxantrone 12 mg/m 2 IV on Day 1; leuconessee. vorin 300 mg IV over 30-60 minutes on Days 1, 2, and 3, immediately preceding